Futurelab Talks: Market Approval

Biomedical entrepreneurs developing a novel medical intervention often have a clear goal in sight: getting past authority approval and moving their invention to patients. Authority approval is mandatory at various milestones in the life cycle of a novel biomedical intervention and the path to obtain and maintain market approval can be difficult to navigate. The Market Approval Futurelab Talks will discuss different aspects and possible pitfalls when bringing your biomed intervention to market.

This event is now closed.

Read the blog article.

At Paul Janssen Futurelab, we are developing a blended course Market Approval for ambitious postgraduate biomedical researchers who wish to further their career and increase their knowledge on authority approval and regulatory affairs. The Futurelab talks are part of this course and you will have a unique opportunity to be inspired by experts in the field who discuss key aspects of market approval. Seating is limited, so please sign up to attend this event.


Date: Friday, November 16
14:00-17:00 h

Venue: Kapelzaal Leidse Volkshuis
Oude Vest 45, 2312 XS Leiden
(B plus C, entrance Hazewindsteeg)

Costs: Free, sign up required


Paul Janssen Futurelab

Futurelab Talks are inspirational presentations from experts who contribute to the blended courses from Paul Janssen Futurelab Leiden. These talks will be filmed and recorded for the new blended course Market Approval.

Futurelab Talks: Market Approval

Bernd van der Meulen

European Institute for Food Law / Renmin University of China Law School

Professor of Comparative Food Law

Futurelab Talks: Market Approval

Henk Schuring


VP-Head Rare Nephrology

Futurelab Talks: Market Approval

Sjaak Bot


Former VP, Head of EMEA Regulatory Affairs

Futurelab Talks: Market Approval

Bert Leufkens

Utrecht Institute for Pharmaceutical Sciences (UIPS)

Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board